AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry challenges like the "patent cliff" and high clinical failure rates. AI-driven ...
FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and innovation across the life cycle of a drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results